E2F1 and breast neoplasm: Scatter plots of E2F1 versus ER and ERBB2 expression levels in the STB data set (Figure 1a,b) revealed that ER-negative and ERBB2-positive breast tumors typically expressed high levels of E2F1, whereas in contrast low E2F1 levels (below the 30th percentile of its distribution in this collective) were detected almost exclusively in ER-positive and ERBB2-negative breast tumors.